In-Kind IPO Investor in the Biotech/Pharma IPO
Company is a leading in-kind investor in IPO of the biotech and drug discovery companies in the USA, France, Austria, and the UK. We believe that these sectors hold great potential for growth and innovation, and we are proud to support these companies as they work to bring their ideas to market.
Company is looking for fully audited companies with the business based in the USA or Europe considering an IPO.
Company excels in offering a streamlined and transparent approach to in-kind IPO investments, thus enhancing the flexibility and adaptability of businesses. Our meticulous analysis of documents and thoughtful solutions are designed to create a seamless and mutually beneficial transaction experience. We firmly believe that our approach not only saves valuable time but also contributes to the creation of the most optimal transaction, ultimately fostering success for all parties involved.
Financials (USD)
Maximum Amount Not Disclosed
Converted From EUR
Exchange Rate $1.17
Disclaimer: DealStream has not independently verified any of the information in this listing and makes no warranty as to its accuracy or completeness. This listing does not constitute an offer to sell, solicit or make an offer to buy an investment interest. Offers to sell, or the solicitation of offers to buy, any security can only be made through official offering documents, such as a subscription agreement and private placement memorandum. Read DealStream's Terms Of Use before responding to any listing. Learn how to stay safe in our marketplace.
Request Information
Want to learn more about this listing? Log in now. New to DealStream? Discover how artificial intelligence can help you find better deals! Sign up for a Free Account today and get your first Search Genius deal tomorrow.
Sign UpDealStream Awards & Reviews
